The Cancer Immunology Discovery group at Pfizer is seeking an ambitious Post-Doctoral Research Scientist with strong research and communication skills to undertake a highly visible research project shared between the CID and BioMedicine Design groups. The successful candidate will aim to leverage mRNA lipid nanoparticle (mRNA-LNP) technology to enhance T cell activity against tumors. This work will depend heavily on the candidate’s ability to derive novel in vitro/in vivo experimental models and complete related experiments to give an early glimpse at the clinical potential of this approach.
We are seeking a self-starting, highly motivated, and technically proficient scientist with a PhD in Immunology or Cancer Biology to apply a variety of cutting-edge tools including molecular, cellular, and biochemical techniques alongside immunofluorescence imaging, high parameter flow cytometry, and bioinformatics in preclinical in vivo models to address key questions within the scope of the proposed work. (S)he will work in a fast-paced and highly collaborative research environment and will be expected to present their findings in high-impact journals and at internal and external scientific conferences.
OTHER JOB DETAILS
Eligible for Relocation Assistance
Must Have Work Authorization in US
The annual base salary for this position ranges from $59,200.00 to $94,800.00. In addition, this position offers an annual bonus with a target of 7.5% of the base salary. Benefits offered include a retirement savings plan, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage in accordance with the terms and conditions of the applicable plans. Salary range does not apply to the Tampa, FL location.
Relocation assistance may be available based on business needs and/or eligibility.
Pfizer requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Pfizer will consider requests for Reasonable Accommodations.
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.
Research and Development
Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives. We make medicines and vaccines that help people when they are sick and prevent them from getting sick in the first place. Every day, our colleagues work in developed and emerging markets to ...